| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 143 |
| 1 | RUXOLITINIB | 74 |
| 2 | AZACITIDINE FOR | 71 |
| 3 | LENALIDOMIDE | 61 |
| 4 | CYTARABINE | 59 |
| 5 | DARBEPOETIN ALFA | 56 |
| 6 | BLINATUMOMAB | 55 |
| 7 | VENETOCLAX | 52 |
| 8 | CYCLOPHOSPHAMIDE | 43 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUSPATERCEPT | 38 | 0.0145 |
| 1 | BLINATUMOMAB | 55 | 0.0051 |
| 2 | CHLORAMBUCIL | 20 | 0.0051 |
| 3 | CARMUSTINE | 23 | 0.0049 |
| 4 | AZACITIDINE | 143 | 0.0047 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 11 | 0.0045 |
| 6 | CEDAZURIDINE AND DECITABINE | 4 | 0.0041 |
| 7 | MOMELOTINIB | 6 | 0.0041 |
| 8 | IDARUBICIN HYDROCHLORIDE | 3 | 0.0026 |
| 9 | IDECABTAGENE VICLEUCEL | 3 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 196 |
| 1 | Kinase Inhibitor [EPC] | 88 |
| 2 | Janus Kinase Inhibitor [EPC] | 74 |
| 3 | Corticosteroid [EPC] | 62 |
| 4 | Thalidomide Analog [EPC] | 62 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 56 |
| 6 | Alkylating Drug [EPC] | 55 |
| 7 | BCL-2 Inhibitor [EPC] | 52 |
| 8 | Platinum-based Drug [EPC] | 45 |
| 9 | Erythroid Maturation Agent [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 38 | 0.0145 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 11 | 0.0045 |
| 2 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |
| 3 | Actinomycin [EPC] | 3 | 0.0014 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 56 | 0.0010 |
| 5 | BCL-2 Inhibitor [EPC] | 52 | 0.0008 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 196 | 0.0007 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 15 | 0.0007 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 9 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |